Lund Melanoma Study Group
71 – 80 of 245
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
Coignard, Juliette ; Augustinsson, Annelie LU ; Olsson, Håkan LU
; Borg, Åke
LU
and Antoniou, Antonis C
(2021)
In Nature Communications
12(1).
- Contribution to journal › Article
-
Mark
Non-radical primary diagnostic biopsies affect survival in cutaneous head and neck melanoma
Greiff, Lennart LU ; Skogvall-Svensson, Ingela LU ; Carneiro, Ana LU
and Hafström, Anna
LU
(2021)
In Acta Oto-Laryngologica
141(3).
p.309-319
- Contribution to journal › Article
-
Mark
Survival in 31 670 patients with thin melanomas : a Swedish population-based study
Isaksson, K LU ; Mikiver, R ; Eriksson, H ; Lapins, J ; Nielsen, K LU
; Ingvar, C
LU
and Lyth, J
(2021)
In The British journal of dermatology
184(1).
- Contribution to journal › Article
-
Mark
Surgery of metastatic melanoma after systemic therapy–the SUMMIST trial : study protocol for a randomized controlled trial
Holmberg, Carl Jacob ; Katsarelias, Dimitrios ; Jespersen, Henrik ; Carneiro, Ana LU
; Elander, Nils O.
; Helgadottir, Hildur
; Isaksson, Karolin
LU
; Jansson, Malin
; Wirén, Sara
and Ullenhag, Gustav J.
, et al.
(2021)
In Acta Oncologica
60(1).
p.52-55
- Contribution to journal › Letter
-
Mark
Breast cancer risk factors and survival by tumor subtype : pooled analyses from the Breast Cancer Association Consortium
(2021) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 30(4). p.623-642
- Contribution to journal › Article
-
Mark
PTENP1-AS contributes to BRAF inhibitor resistance and is associated with adverse clinical outcome in stage III melanoma
Vidarsdottir, Linda ; Azimi, Alireza ; Das, Ishani ; Sigvaldadottir, Ingibjorg ; Suryo Rahmanto, Aldwin ; Petri, Andreas ; Kauppinen, Sakari ; Ingvar, Christian LU ; Jönsson, Göran LU and Olsson, Håkan LU
, et al.
(2021)
In Scientific Reports
11(1).
- Contribution to journal › Article
-
Mark
The Prognostic Impact of Intratumoral Aryl Hydrocarbon Receptor in Primary Breast Cancer Depends on the Type of Endocrine Therapy : A Population-Based Cohort Study
Tryggvadottir, Helga LU ; Sandén, Emma LU ; Björner, Sofie LU ; Bressan, Alessandra ; Ygland Rödström, Maria ; Khazaei, Somayeh LU ; Edwards, Dean P. ; Nodin, Björn LU ; Jirström, Karin LU
and Isaksson, Karolin
LU
, et al.
(2021)
In Frontiers in Oncology
11.
- Contribution to journal › Article
-
Mark
Multiple primary melanoma incidence trends over five decades, a nation-wide population-based study
Helgadottir, Hildur ; Isaksson, Karolin LU ; Fritz, Ildiko LU ; Ingvar, Christian LU ; Lapins, Jan ; Höiom, Veronica ; Newton-Bishop, Julia and Olsson, Håkan LU
(2021)
In Journal of the National Cancer Institute
113(3).
p.318-328
- Contribution to journal › Article
-
Mark
Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanoma
- Contribution to journal › Article
-
Mark
Rapid Identification of the Tumor-Specific Reactive TIL Repertoire via Combined Detection of CD137, TNF, and IFNγ, Following Recognition of Autologous Tumor-Antigens
Draghi, Arianna ; Chamberlain, Christopher Aled ; Khan, Shawez ; Papp, Krisztian ; Lauss, Martin LU ; Soraggi, Samuele ; Radic, Haja Dominike ; Presti, Mario ; Harbst, Katja LU
and Gokuldass, Aishwarya
, et al.
(2021)
In Frontiers in Immunology
12.
- Contribution to journal › Article